Interleukin (IL)-10, IL-12, and interferon-γ production in primary and memory immune responses to Varicella-Zoster virus

Journal of Infectious Diseases

Volumn 178, Issue 4, 1998, Pages 940-948

  Jenkins, Darlene E ^a,b   Redman, Rebecca L ^a   Lam, Eu Meng ^a   Liu, Catherine ^a   Lin, Ines ^a   Arvin, Ann M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Xenogen   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12;

ADULT; ANTIBODY PRODUCTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; IMMUNIZATION; IMMUNOLOGICAL MEMORY; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VARICELLA ZOSTER VIRUS;

EID: 0031686767     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515702     Document Type: Article

References (19)

1. Arvin AM. Varicella-zoster virus. In: Fields BN, ed. Virology. New York: Raven, 1995:2547-86.
2. Straus SE. Overview: the biology of varicella-zoster virus infection. Ann Neurol 1994;35(suppl):S4-8.
3. Lungu O, Annunziato PW, Gershon A, et al. Reactivated and latent varicella-zoster virus in human dorsal root ganglia. Proc Natl Acad Sci USA 1995;92:10980-4.
4. + T lymphocytes and epidermal cells in SCID-hu mice. J Virol 1995;69:5236-42.
5. Arvin AM. Immune responses to varicella-zoster virus. Philadelphia: WB Saunders, 1996.
6. + phenotype. J Immunol 1991;146:257-64.
7. Grose C. Glycoproteins of varicella-zoster virus and their herpes simplex virus homologs. Rev Infect Dis 1991;13(suppl 11):S960-3.
8. Hayward A, Pontesilli O, Herberger M, Laszlo M, Levin M. Specific lysis of varicella-zoster virus-infected B lymphoblasts by human T cells. J Virol 1986;58:179-84.
9. Hayward AR. T-cell responses to predicted amphipathic peptides of varicella-zoster virus glycoproteins II and IV. J Virol 1990;64:651-5.
10. Zhang Y, Cosyns M, Levin MJ, Hayward AR. Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures. Clin Exp Immunol 1994;98:128-33.
11. + T cells. Annu Rev Immunol 1994;12:635-73.
12. Redman RL, Nader S, Zerboni L, et al. Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine. J Infect Dis 1997;176:578-85.
13. + T cells requires repeated antigenic stimulation. Cell Immunol 1993;152:18-34.
14. Cousens LP, Orange JS, Su HC, Biron CA. Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc Natl Acad Sci USA 1997;94:634-9.
15. Orange JS, Salazar-Mather TP, Opal SM, et al. Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J Exp Med 1995;181:901-14.
16. Orange JS, Wang B, Terhorst C, Biron CA. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med 1995;182:1045-56.
17. Kanangat S, Thomas J, Gangappa S, Babu JS, Rouse BT. Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression. Implications in immunopathogenesis and protection. J Immunol 1996;156:1110-6.
18. Graziosi C, Vaccarezza M, Demarest JF, et al. Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection. Proc Natl Acad Sci USA 1995;93:4386-91.
19. Arvin AM, Koropchak CM, Williams BR, Grumet FC, Foung SK. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J Infect Dis 1986;154:422-9.